UK Govt Spent £16m on Two Million Chinese-Made

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
219
UK Govt Spent £16m on Two Million
Chinese-Made Coronavirus Tests that
Didn’t Work < >

Chinese-coronavirus-640x480.jpg

The British government reportedly spent £16 million on two million coronavirus home test kits from two separate Chinese companies, none of which work.

The New York Times claimed on Friday that a laboratory at Oxford University found that the tests, intended to be rolled out as home kits, were insufficiently accurate at detecting antibodies. The American newspaper alleged that half a million from one company are now in storage and the other 1.5 million from the second Chinese firm have also gone unused. The tests were manufactured by AllTest Biotech and Wondfo Biotech, both of which claim that their products met European Union (EU) standards.

Following complaints from the British government that the tests were useless, both Chinese companies attempted to blame British officials for misunderstanding how the tests worked, with Wanfo Biotech claiming that the test for only to be used supplementarily for patients who already knew that they had the virus.

A spokesman from the Department of Health and Social Care told the newspaper that the government had ordered the smallest batch the vendors would sell, and it would seek to recuperate taxpayers’ money for the faulty medical equipment.

It is unclear if these tests are the very same batch of millions of faulty Chinese-made tests that the British government admitted to having bought at the beginning of this month.

Professor John Newton of Public Health England (PHE) — the government’s official executive agency responsible for public health in England — had said that the Chinese tests had been validated against patients who had been severely ill. In contrast, the United Kingdom needed tests that required a range of infection levels to pick up those with the antibodies.

However, the New York Times report may point to the scale of taxpayers’ money being spent on faulty medical equipment purchased from the very country where the pandemic originated.

Sue Communist China for Coronavirus Pandemic, Says British Think Tank https://t.co/l0oC6EFqyO

— Breitbart London (@BreitbartLondon) April 6, 2020

The Daily Mail said that Downing Street did not deny the claims put out by the NYT, but a spokesman for Prime Minister Boris Johnson said he was not aware of the specific £16 million figure. The spokesman told the British newspaper: “Where tests are shown not to have any prospect of working then we will seek to recover as much of the costs as we can.”

A Department of Health and Social Care spokesman also told The Sun: “We are currently working with a number of companies on finding fast, reliable antibody tests and are in the process of evaluating their effectiveness.

“These tests could be transformational, and we are working round the clock to gain regulatory approval. It is crucial we are satisfied of their safety and accuracy before making them available.

“We have bought our current stock on the basis of minimum initial volumes, which are being clinically tested. If tests don’t work, orders will be cancelled, and costs recovered wherever possible.”

If the reports are accurate, it would fit the profile of Chinese companies taking advantage of European countries in crisis by selling them shoddy or overpriced equipment. Last month, the Netherlands had to recall 600,000 masks sent from China that were found to have faulty filters, for example.

Spain also had received thousands of coronavirus tests from Chinese company Shenzen Bioeasy Biotechnology Company Limited which proved useless. Again, the company claimed that its products were EU certified.

China’s communist regime also attempted to avoid responsibility, with the Chinese embassy in Madrid implying that the Spanish government was at fault.

A diplomatic source in Spain had warned that Chinese companies were taking advantage of the situation, with some costs increasing by tenfold and companies in China demanding payment upfront.

Farage: Huawei in UK 5G May Be Price for Accepting China’s Coronavirus Aid https://t.co/mCgrCfsoj7

— Breitbart London (@BreitbartLondon) April 7, 2020

The United Kingdom, Spain, and the Netherlands are just a handful of Western countries desperately scrambling to obtain vital personal protection equipment, medicines, ventilators, and tests from Chinese suppliers because their own domestic supply chains have been decimated by decades of globalisation.

Writing last month, Brexit Party leader Nigel Farage said that the Chinese coronavirus pandemic had exposed the West’s dependency on China in its supply chains. Italy, the epicentre of the epidemic, has been forced to accept support from Xi Jinping’s communist regime due to the EU’s failure to help its member-state.

Mr Farage wrote of the situation: “To see China now exploiting a crisis that they have caused to spread their influence further and deeper into Europe should send a chill down our spines.”

Mr Farage also warned in April that Chinese interests are lining up to take advantage of the economic disruption caused by the Chinese coronavirus crisis hoping for a “fire sale” of British businesses so they can buy up “vast swathes of our strategic and manufacturing industries”.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rising Medical Lands Ninth Spot on Inc. 5000

Updated Category News Views 105

Rising Medical's Continued Ascent In a world where the list of high-performing companies is as long as a trader's bad day, Rising Medical Solutions, out of Chicago, has snagged its ninth appearance on the Inc. 5000 list. This isn’t just any roll call; we're talking about a spotlight for America’s fastest-growing private companies—a badge of honor for business...

Continue Reading
Atlas-SSI Expands Grip in Water Control Space

Updated Category News Views 101

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Continue Reading
GreenCore's Agentic Shopping Hub: Disrupting FMCG Market

Updated Category News Views 34

GreenCore's Bold Move in FMCG Retail Just when you thought retail couldn't get any more futuristic, here comes GreenCore Solutions Corp. (GSC) shaking up the game with their Agentic Shopping Hub. For the uninitiated, we're not just talking about another e-commerce gimmick—this is a cultural shift. FMCG brands are being told to 'bring their agent' into a realm where AI...

Continue Reading
JELD-WEN Q3 2026: Fighting Headwinds, Shows Progress

Updated Category News Views 24

Challenging Market Yet Strategic Steps Talk about a seesaw of a quarter for JELD-WEN, folks. On the one hand, their net revenues took a dip to $798.5 million, shaving off 1.4% from last year. If you ask why, blame it on a 2% slide in volume/mix. That uptick in price? Well, 1% wasn't enough to save the day. "Our third-quarter results reflect the continued progress we are...

Continue Reading
Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 215

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading
Doximity Faces Class Action: Investor Guidance Needed

Updated Category News Views 54

Doximity Lands in Hot Water: The Stakes for Investors Alright, traders, there's a storm brewing around Doximity (NYSE:DOCS), and it's a doozy. A class action lawsuit has been slapped on this digital platform for medical pros, and the accusations are serious. If you rode the wave and snagged yourself some shares between August 8, 2024, and May 13, 2026, you're right in the...

Continue Reading
Metals Producers Rise Despite Futures Dip: Election Day Buzz

Updated Category News Views 40

Election Day Drama: Metals Market Jitters You'd think with all the election day hoopla, the metal futures would hold steady. But here we are, seeing gold, silver, and copper futures retracting like a scared turtle. Monday, they all roared upward. Tuesday morning, they're backpedaling. December gold futures took a hit, dropping 0.78% to land at $3,938.50 an ounce. Silver...

Continue Reading
Zuellig Pharma Expands Clinical Capabilities in China

Updated Category News Views 34

Zuellig Pharma's Strategic Leap in Hangzhou You know, in the ever-evolving world of biotech and pharmaceuticals, setting up shop in the right locale can mean the difference between breakthroughs and breakdowns. So Zuellig Pharma—a major player, but not exactly a household ticker—made a smart move acquiring a clinical facility in Hangzhou. This is no minor shuffle;...

Continue Reading
Qfin Holdings Faces Securities Fraud Class Action Challenges

Updated Category News Views 73

Troubles Mount for Qfin Holdings Well, you don't need a crystal ball to see this storm brewing for Qfin Holdings, Inc. (NASDAQ:QFIN). On the heels of a nasty 18.91% nosedive in their stock price, a class action lawsuit is looming overhead like a mischievous cloud ready to rain on investors' parades. It's the kind of legal and financial brew that could leave shareholders...

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 53

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading

Top 5 Most Recently Viewed Articles

Swisslog and Medline Enhance Supply Chain with Automation Solution

Updated Category News Views 181

Swisslog and Medline Enhance Supply Chain with Automation Solution Swisslog, a recognized leader in logistics automation, has embarked on an exciting new project with Medline, a long-standing partner. This collaboration focuses on the implementation of an advanced AutoStore system designed to significantly enhance Medline's order fulfillment capabilities. The New...

Continue Reading
Revolutionizing Healthcare with Wearable Electronic Records

Updated Category News Views 149

Revolutionizing Healthcare with Wearable Electronic Records In an exciting advancement for digital health, Retrieve Medical Holdings, Inc. (OTC Pink: RMHI) has announced a groundbreaking partnership with MyID, a leader in wearable medical identification technology. This joint venture aims to introduce the first-ever device that integrates a user’s complete, verified...

Continue Reading
Innovative EVV Solutions Introduced for Care Providers in Michigan

Updated Category News Views 112

Therap Integrates with EVV Aggregator for Enhanced Care Therap Services, a leader in HIPAA-compliant electronic documentation solutions, is taking significant strides forward in support of care providers. By integrating with a new Electronic Visit Verification (EVV) aggregator, Therap aims to enhance the services provided to patients receiving Medicaid personal care and...

Continue Reading
Jabil's Bright Future: Earnings Surge and Strategic Growth Ahead

Updated Category News Views 223

Jabil's stock saw some serious action back in 2024 when BofA Securities hiked its price target from $135 to $150 after a strong Q4 earnings report. They slapped a Buy rating on it, and you know how that goes—traders perk up when the analysts start buzzing about positive outlooks. For fiscal year 2025, Jabil was predicting revenues of around $27 billion and an EPS of...

Continue Reading
AdTech Holding Celebrates Prestigious Workplace Certification

Updated Category News Views 110

AdTech Holding Achieves Recognition for Workplace Excellence AdTech Holding has recently earned the esteemed Great Place To Work® Certification™ for the third consecutive year. This notable achievement reflects the genuine feedback from employees concerning the workplace culture, trust, and the opportunities for professional growth that the company fosters. A...

Continue Reading